ARMISTICE CAPITAL, LLC

Holdings History for BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)

Symbol: BTAI on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share
Latest Disclosed Shares Owned: 288,131 shares
Security Ownership %: 5%

Armistice Capital, LLC ownership in BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI)

15 May 2025 - Armistice Capital, LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 288,131 shares of BioXcel Therapeutics, Inc. Common Stock, par value $0.001 per share (BTAI). This represents 5% ownership of the company. In their previous filing dated 14 Feb 2025, ARMISTICE CAPITAL, LLC had reported owning 4,997,275 shares, indicating a decrease of +94%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Armistice Capital, LLC	5%	-50%	$564,737	288,131	-4,709,144	-94%	$1.96	13G/A	31 Mar 2025	15 May 2025, 15:33
Armistice Capital, LLC	10%		$9,794,659	4,997,275			$1.96	13G	31 Dec 2024	14 Feb 2025, 17:27